ARK Levetiracetam II Assay— 510(k) K232522

Substantially Equivalent

Ark Diagnostics, Inc.

FDA 510(k) clearance K232522 for ARK Levetiracetam II Assay, Substantially Equivalent on 2024-02-27. Applicant: Ark Diagnostics, Inc..

Clearance details

Applicant
Ark Diagnostics, Inc.
Product code
Code ORI
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Fremont, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.